KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $47.0 million.

  • Teladoc Health's Net Cash Flow fell 4110.76% to $47.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$519.5 million, marking a year-over-year decrease of 34571.79%. This contributed to the annual value of $177.9 million for FY2024, which is 1299.97% down from last year.
  • According to the latest figures from Q3 2025, Teladoc Health's Net Cash Flow is $47.0 million, which was down 4110.76% from -$518.2 million recorded in Q2 2025.
  • In the past 5 years, Teladoc Health's Net Cash Flow registered a high of $91.8 million during Q4 2023, and its lowest value of -$518.2 million during Q2 2025.
  • For the 5-year period, Teladoc Health's Net Cash Flow averaged around -$281842.1, with its median value being $46.3 million (2022).
  • In the last 5 years, Teladoc Health's Net Cash Flow skyrocketed by 47236.11% in 2023 and then tumbled by 90042.79% in 2025.
  • Over the past 5 years, Teladoc Health's Net Cash Flow (Quarter) stood at $69.8 million in 2021, then tumbled by 77.01% to $16.0 million in 2022, then skyrocketed by 472.36% to $91.8 million in 2023, then tumbled by 36.48% to $58.3 million in 2024, then dropped by 19.49% to $47.0 million in 2025.
  • Its Net Cash Flow was $47.0 million in Q3 2025, compared to -$518.2 million in Q2 2025 and -$106.6 million in Q1 2025.